In vitro and in vivo antibacterial activities of telithromycin

Chemotherapy

Volumn 49, Issue 1-2, 2003, Pages 62-65

  Mikamo, Hiroshige ^a   Yin, Xiang Hua ^a   Ninomiya, Mochiyoshi ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibacterial activity; Ketolide; Telithromycin

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; LEVOFLOXACIN; TELITHROMYCIN;

ABDOMINAL ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; ENTEROCOCCUS FAECALIS; FEMALE; FINEGOLDIA MAGNA; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; PEPTOSTREPTOCOCCUS; PEPTOSTREPTOCOCCUS ANAEROBIUS; PREVOTELLA BIVIA; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

ABDOMINAL ABSCESS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTEROIDACEAE; BACTEROIDES FRAGILIS; ENTEROCOCCUS FAECALIS; FEMALE; GENITAL DISEASES, FEMALE; GRAM-NEGATIVE AEROBIC RODS AND COCCI; GRAM-POSITIVE COCCI; KETOLIDES; MACROLIDES; MICE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PEPTOSTREPTOCOCCUS; PREVOTELLA; STREPTOCOCCUS AGALACTIAE;

EID: 0037266431     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069789     Document Type: Article

References (9)

1. Bryskier A, Agouridas C, Chantot J-F: Ketolides: New semisynthetic 14-membered-ring macrolides; in Zinner SH, Young LS, Acar JA, Neu HC (eds): Expanding Indications for the New Macrolides, Azalides and Streptogramins. New York, Marcel Dekker, 1997, pp 39-50.
2. Jones RN, Biedenbach DJ: Antimicrobial activity of RU66647, a new ketolide. Diagn Microbiol Infect Dis 1997;27:7-12.
3. Edlund C, Sillerstrom E, Wahlund E, Nord CE: In vitro activity of HMR 3647 against anaerobic bacteria. J Chemother 1998;10:280-284.
4. Mikamo H, Hua YX, Sato Y, Hayasaki Y, Tamaya T: In vitro antibacterial activities of telithromycin, a new ketolide, against bacteria causing infections in obstetric and gynaecological patients. J Antimicrob Chemother 2000;46:332-334.
5. Mikamo H, Kawazoe K, Sato Y, Izumi K, Tamaya T: Studies on the clinical implications of anaerobes, especially Prevotella bivia, in obstetrics and gynecology. J Infect Chemother 1998;4:177-187.
6. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, ed 5. NCCLS Document M7-A5. Villanova, National Committee for Clinical Laboratory Standards, 2000, vol 20, No. 2.
7. National Committee for Clinical Laboratory Standards: Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, ed 2. NCCLS Document M11-A4. Villanova, National Committee for Clinical Laboratory Standards, 2001, vol 21, No 2.
8. Weinstein WM, Onderdonk AB, Bartlett JG, Gorbach SL: Experimental intraabdominal abscesses in rats: Development of an experimental model. Infect Immun 1974;10:1250-1255.
9. Weinstein WM, Onderdonk AB, Bartlett JG, Louie TJ, Gorbach SL: Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis 1975;132:282-286.